Live Breaking News & Updates on Novel Alzheimer

The FDA today approved a new therapy for early Alzheimer s disease that appears to modestly slow the progression of the disease that affects more than 6.5 million Americans. ....

United States , Teresa Buracchio , Medicaid Services , Us Medicare Program , Centers For Medicare , Office Of Neuroscience , Drug Evaluation , Novel Alzheimer , Disease Treatment , Traditional Approval , Annual Spending , Its Ancillary Costs , Alzheimers Disease , Lzheimer Disease , Us Food And Drug Administration , Nited States Food And Drug Administration , Cognitive Deficit , Memory Problems , Cognitive Impairment , Amyloid Plaque ,